• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

Introduction to 2-2-(difluoromethoxy)-5-fluorophenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAS No. 1417301-27-9)

2-2-(difluoromethoxy)-5-fluorophenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, identified by its CAS number 1417301-27-9, is a specialized organoboron compound that has garnered significant attention in the field of synthetic chemistry and pharmaceutical research. This boryl ether derivative is characterized by its unique structural features, including a difluoromethoxy substituent and a fluorophenyl ring, which contribute to its remarkable reactivity and utility in cross-coupling reactions. The presence of a tetramethyl-substituted dioxaborolane core enhances its stability and makes it an attractive intermediate in the synthesis of complex organic molecules.

The compound belongs to the class of boronic esters, which are widely employed in Suzuki-Miyaura cross-coupling reactions. These reactions are fundamental in modern organic synthesis, enabling the formation of carbon-carbon bonds under mild conditions with high selectivity. The difluoromethoxy group in this molecule imparts additional electronic properties, influencing both the reactivity and the electronic environment of the boron center. This feature makes it particularly valuable for applications in the development of novel pharmaceuticals and agrochemicals.

In recent years, there has been a surge in research focused on fluorinated compounds due to their enhanced metabolic stability and improved binding affinity to biological targets. The fluorophenyl moiety in 2-2-(difluoromethoxy)-5-fluorophenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane contributes to these desirable properties. Fluoroaromatics are known to exhibit stronger interactions with enzymes and receptors compared to their hydrogenated counterparts, making them indispensable in drug design. The combination of these structural elements makes this compound a versatile building block for medicinal chemists.

One of the most compelling aspects of this compound is its role in the synthesis of biologically active molecules. Researchers have leveraged its reactivity to develop novel heterocyclic scaffolds and functionalized aromatic systems. For instance, recent studies have demonstrated its utility in constructing complex drug candidates targeting neurological disorders. The tetramethyl-substituted dioxaborolane core provides steric hindrance that can be tailored to optimize binding interactions within biological systems. This level of control is crucial for designing molecules with improved pharmacokinetic profiles.

The pharmaceutical industry has increasingly recognized the importance of boronic acids and esters in drug development. Boron-containing compounds have shown promise in various therapeutic areas, including oncology and inflammation. The ability to introduce fluorine atoms further enhances their potential by improving lipophilicity and reducing metabolic degradation. This has led to several clinical trials investigating boron-containing drugs with fluorine modifications.

Moreover, advancements in synthetic methodologies have expanded the applications of 2-2-(difluoromethoxy)-5-fluorophenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. Techniques such as flow chemistry and photoredox catalysis have enabled more efficient and scalable preparations of this intermediate. These innovations are particularly relevant in industrial settings where cost-effectiveness and reproducibility are paramount.

In academic research, this compound has been utilized as a key precursor in developing new catalysts for cross-coupling reactions. The unique electronic properties of the difluoromethoxy group allow for fine-tuning of catalyst performance. Recent publications highlight its use in designing ligands that enhance reaction rates while maintaining high selectivity. Such developments are critical for streamlining synthetic routes and reducing waste.

The environmental impact of chemical synthesis has also driven interest in greener alternatives. Boronic esters offer a sustainable approach compared to traditional halogenated reagents due to their lower toxicity profiles. The stability provided by the tetramethyl-substituted dioxaborolane core ensures that these compounds remain viable intermediates throughout multi-step syntheses without degradation.

Future directions in research may explore the use of 2-2-(difluoromethoxy)-5-fluorophenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane in biocatalysis and enzymatic transformations. Its compatibility with various reaction conditions makes it a candidate for integrating into enzymatic cascades where multiple transformations can occur under mild conditions mimicking biological processes.

In conclusion,2-2-(difluoromethoxy)-5-fluorophenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (CAS No. 1417301-27-9) represents a significant advancement in synthetic chemistry with broad implications for pharmaceutical development. Its unique structural features make it an invaluable tool for constructing complex molecules with enhanced biological activity. As research continues to uncover new applications for this compound,tetramethyl-substituted dioxaborolanes, particularly those incorporating fluorine and methoxy functionalities,will remain at the forefront of innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)